Prior to receiving CAR T-cell therapy, patients undergo lymphodepletion chemotherapy, explained Kerry Rogers, MD, The James.

The FDA approved Moderna’s Biologics License Application (BLA) for its mRNA-based flu vaccine, mRNA-1010 (mFlusiva; Moderna), ...

Disease-modifying antirheumatic drug (DMARD) and tumor necrosis factor (TNF) cycling is a real and well-documented problem in ...

Katherine Wilemon, Family Heart Foundation, described the biggest unmet need when it comes to public awareness of Lp(a) and ...

A quasi-experimental difference-in-differences analysis of Virginia claims quantified NSAID dispensing in higher-risk cardiorenal populations across 2019–2021 and estimated pandemic-associated ...

Constrained optimization empirically derived social risk weights that gave equal influence to subgroup performance by dual ...

Accelerated approval positions RP1 plus nivolumab for advanced melanoma after progression on prior anti–PD-1 therapy, following two CRLs and a 10–3 advisory committee recommendation. In IGNYTE (n=140) ...

Noureddin framed the emergence of dual GLP-1/glucagon receptor agonism as a significant development, placing it alongside artificial intelligence as a transformative force in medicine, noting that ...

Prior authorization, coverage limits, and affordability screening increasingly determine when CAR T or bispecifics are ...

Eligibility definitions differ across reports, particularly whether prior failure on highest approved antiobesity dose is required versus documenting discussion of all standard treatments. A one-off ...

UPMC and Birth Root Community Doula describe a 4-year partnership addressing food insecurity, housing, and maternal health ...